Form 4: Castle Biosciences Director Harrison Miles Reports Stock Transactions
SEC Form 4 Filing
Director Harrison Miles of Castle Biosciences reports the vesting and subsequent disposal of 8,636 shares of common stock related to restricted stock units.
Summary
- On May 25, 2024, Harrison Miles, a director at Castle Biosciences, had 8,636 Restricted Stock Units (RSUs) vest.
- Each RSU represents the right to receive one share of Castle Biosciences' common stock.
- Upon vesting, these 8,636 shares were disposed of.
- Following the reported transaction, Miles still beneficially owns 13,291 shares of Castle Biosciences common stock.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company director, and doesn't inherently indicate positive or negative sentiment. It's a neutral event in terms of company performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard disclosure of insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 05/25/2024 | Date of transaction: Vesting and disposal of Restricted Stock Units. |
| 05/29/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.